Baxter International Inc. $BAX Shares Purchased by Police & Firemen s Retirement System of New Jersey

Police & Firemen s Retirement System of New Jersey raised its holdings in shares of Baxter International Inc. (NYSE:BAX) by 4.9% in the 2nd quarter, Holdings Channel reports. The firm owned 77,419 shares of the medical instruments supplier’s stock after purchasing an additional 3,588 shares during the quarter. Police & Firemen s Retirement System of New Jersey’s holdings in Baxter International were worth $2,344,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently modified their holdings of BAX. Dodge & Cox boosted its holdings in shares of Baxter International by 2.1% in the 1st quarter. Dodge & Cox now owns 51,458,925 shares of the medical instruments supplier’s stock valued at $1,761,439,000 after buying an additional 1,081,631 shares during the period. Geode Capital Management LLC lifted its holdings in Baxter International by 2.6% in the second quarter. Geode Capital Management LLC now owns 12,882,960 shares of the medical instruments supplier’s stock worth $388,416,000 after acquiring an additional 326,652 shares during the last quarter. Ameriprise Financial Inc. boosted its stake in Baxter International by 1.1% in the first quarter. Ameriprise Financial Inc. now owns 7,540,942 shares of the medical instruments supplier’s stock valued at $258,140,000 after acquiring an additional 83,973 shares during the period. Sound Shore Management Inc. CT grew its holdings in shares of Baxter International by 13.7% during the first quarter. Sound Shore Management Inc. CT now owns 2,825,902 shares of the medical instruments supplier’s stock valued at $96,731,000 after purchasing an additional 341,321 shares during the last quarter. Finally, Cooke & Bieler LP raised its position in shares of Baxter International by 10.8% during the 2nd quarter. Cooke & Bieler LP now owns 1,750,510 shares of the medical instruments supplier’s stock worth $53,005,000 after purchasing an additional 170,560 shares during the period. 90.19% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms recently issued reports on BAX. Evercore ISI reduced their price objective on Baxter International from $31.00 to $24.00 in a research report on Thursday, October 30th. Citigroup reduced their price target on shares of Baxter International from $26.00 to $21.00 and set a “neutral” rating for the company in a report on Friday, October 31st. The Goldman Sachs Group dropped their price objective on shares of Baxter International from $25.00 to $22.00 and set a “neutral” rating on the stock in a report on Friday, October 31st. Cowen reissued a “hold” rating on shares of Baxter International in a research note on Thursday, October 30th. Finally, Stifel Nicolaus decreased their target price on shares of Baxter International from $25.00 to $22.00 in a research report on Friday, October 31st. Two analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Reduce” and an average price target of $23.70.

Baxter International Stock Performance

Shares of BAX opened at $17.71 on Thursday. The firm has a market capitalization of $9.10 billion, a PE ratio of -59.02, a P/E/G ratio of 0.73 and a beta of 0.57. The company has a quick ratio of 1.49, a current ratio of 2.30 and a debt-to-equity ratio of 1.30. The firm has a 50-day moving average price of $21.54 and a 200 day moving average price of $25.79. Baxter International Inc. has a 52-week low of $17.40 and a 52-week high of $37.74.

Baxter International (NYSE:BAX) last posted its quarterly earnings data on Thursday, October 30th. The medical instruments supplier reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.60 by $0.09. Baxter International had a negative net margin of 1.42% and a positive return on equity of 16.96%. The business had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.88 billion. During the same quarter last year, the business earned $0.80 earnings per share. The business’s revenue for the quarter was up 5.0% on a year-over-year basis. Baxter International has set its Q4 2025 guidance at 0.520-0.570 EPS. FY 2025 guidance at 2.350-2.400 EPS. On average, sell-side analysts anticipate that Baxter International Inc. will post 2.48 earnings per share for the current fiscal year.

Baxter International Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 2nd. Stockholders of record on Friday, November 28th will be paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, November 28th. Baxter International’s payout ratio is currently -6.06%.

Baxter International Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.